Associated Papers
Epidermal second-hit mutation in MVK gene associated with linear porokeratosis.
Zhao A et al.
Genes & Diseases, 2025
Genetic susceptibility of bladder cancer in the Lebanese population.
Kourie HR et al.
Bmc Medical Genomics, 2022
Association of toll-like receptor polymorphisms with acquisition of HIV infection and clinical findings: A protocol for systematic review and meta-analysis.
Shi H et al.
Medicine, 2020
Toll-like receptor polymorphism in host immune response to infectious diseases: A review.
Mukherjee S et al.
Scandinavian Journal of Immunology, 2019
Human Genetic Variation and HIV/AIDS in Papua New Guinea: Time to Connect the Dots.
Mehlotra RK
Current Hiv/aids Reports, 2018
Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse.
Smetana J et al.
Molecular Cytogenetics, 2018
Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
Chandler MR et al.
Plos One, 2017
Possible role of TLR4 and TLR9 SNPs in protection against congenital toxoplasmosis.
Wujcicka W et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 2015
Toll-like receptor 9 promoter polymorphism as a predictive factor of narrow-band UVB phototherapy response in patients with psoriasis.
Romaní J et al.
Photodermatology, Photoimmunology & Photomedicine, 2015
Association of Single Nucleotide Polymorphisms in Toll-like Receptor Genes With Asthma Risk: A Systematic Review and Meta-analysis.
Tizaoui K et al.
Allergy, Asthma & Immunology Research, 2015
Association of Toll-like receptor polymorphisms with HIV status in North Americans.
Willie B et al.
Genes and Immunity, 2014
G2848A and T-1237C polymorphisms of the TLR9 gene and susceptibility to inflammatory bowel disease in patients from southern Brazil.
Valverde-Villegas JM et al.
Tissue Antigens, 2014
TBX1 mutation identified by exome sequencing in a Japanese family with 22q11.2 deletion syndrome-like craniofacial features and hypocalcemia.
Ogata T et al.
Plos One, 2014
TLR5 stop codon polymorphism is associated with invasive aspergillosis after allogeneic stem cell transplantation.
Grube M et al.
Medical Mycology, 2013
Toll-like receptor variants are associated with infant HIV-1 acquisition and peak plasma HIV-1 RNA level.
Beima-Sofie KM et al.
Aids (london, England), 2013
Role of the functional Toll-Like receptor-9 promoter polymorphism (-1237T/C) in increased risk of end-stage renal disease: a case-control study.
Yang HY et al.
Plos One, 2013
Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells.
Knezević J et al.
The Journal of Biological Chemistry, 2012
The (-1486T/C) promoter polymorphism of the TLR-9 gene is associated with end-stage knee osteoarthritis in a Chinese population.
Su SL et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society, 2012
Immunogenetics of HIV and HIV associated tuberculosis.
Raghavan S et al.
Tuberculosis (edinburgh, Scotland), 2012
The T-1237C polymorphism of the Toll-like receptor-9 gene is associated with chronic kidney disease in a Han Chinese population.
Lu KC et al.
The Tohoku Journal of Experimental Medicine, 2011
Toll-like receptor polymorphisms and susceptibility to human disease.
Misch EA et al.
Clinical Science (london, England : 1979), 2008
Polymorphisms of the toll-like receptor 9 (TLR9) gene with systemic lupus erythematosus in Chinese.
Ng MW et al.
Rheumatology (oxford, England), 2005
An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population.
Noguchi E et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology, 2004
A preliminary assessment of Toll-like receptor and β-defensin gene polymorphisms in Papua New Guinea - what does it mean for HIV/AIDS?
Willie B et al.
Papua and New Guinea Medical Journal, 0